Copy to clipboard 
Montagu, a mid-market private equity firm, announced its support of the merger of Tyber Medical, Intech and Resolve Surgical Technologies.
As part of the transaction, Montagu entered into a definitive agreement to acquire Tyber Medical, a medical device company providing private label development and manufacturing services to med-tech OEMs. Tyber Medical will be combined with Montagu’s existing investments in Resolve, a provider of contract device design, manufacturing and lifecycle management services, as well as in Intech, a leader in the co-development and manufacturing of complex orthopedic surgical devices.
The combined entity will offer a mix of proprietary market-cleared technologies, and development and manufacturing scale, that will enable its OEM customers to achieve speed to market and improve the resiliency and effectiveness of their supply chain. At the time of the merger, the platform will be a leading contract supplier of systems for spine, trauma, extremities, sports medicine and enabling technologies, with plans to expand its model into additional markets. The planned merger will support innovation and help improve standards of care for patients globally.
Jeff Tyber, Founder and CEO at Tyber Medical said: “Tyber Medical’s proven track record of successful global launches, averaging 12 months from signing to launch, has revolutionized how our partners expand their portfolios and adapt to the evolving market dynamics. This strategic combination brings together the size, scale, and expertise of Intech, along with Resolve’s deep knowledge in the Spine and Cardiothoracic fields. We are delighted to be partnering with Montagu, a leading investment firm in the private label OEM sector, and we share their vision of creating an industry champion.“
“This unique combination represents a significant milestone, enhancing our ability to serve medical technology companies worldwide,” said Laurent Pruvost, President and CEO of Intech. “By combining Intech’s global manufacturing footprint and know-how with Resolve and Tyber’s tailored solutions, we will establish ourselves as the undisputed partner of choice in the industry.”
Megan Osorio, President and CEO of Resolve said: “Bringing innovation to market with speed and quality is of the utmost importance to our OEM customers. Joining forces will increase our ability to support their growth across the full range of orthopaedic implants & instruments by bringing the deep experience of our respective teams and scale of our manufacturing footprint together.”
Source: Montagu
